Teva's Credit Rating Cut to Junk by Fitch - Bloomberg
Drugmaker Teva makes $40B bid for rival Mylan
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
Teva to lay off 25% of workforce, suspends dividend - BNN Bloomberg
Teva Sees Adderall Supply Delays Continuing for 2-3 Months (1)
The Adderall supply squeeze in the US is growing
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - Bloomberg
Teva Agrees to Settle Opioid Lawsuits for as Much as $4.25 Billion - WSJ
Teva CEO Calls 'Trough' Revenues Consequence of Patent Expirations - YouTube
Buffett's Berkshire Takes Activision Blizzard Stake, Exits Teva - BNN Bloomberg
Future Teva CEO Seeks to 'Formulate Clear Strategy' - YouTube
Teva flags supply constraints to ADHD drug Adderall as demand rises (NYSE: TEVA) | Seeking Alpha
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - BNN Bloomberg
Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva Is 'on the Way' to Leaving Opioid Litigation Behind, CEO Says | Barron's
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva's Budding Blockbuster Drugs Lend Respite From Legal Concerns - Bloomberg
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Tags search | Ctech
Teva CEO to Meet Netanyahu With Blunt Message on Need for Cuts - Bloomberg
New York jury holds drug firm Teva liable in opioid crisis
